BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 20727133)

  • 21. Interstitial lung disease in systemic sclerosis.
    Bussone G; Mouthon L
    Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating infants and children with interstitial lung disease.
    Deterding R
    Semin Respir Crit Care Med; 2007 Jun; 28(3):333-41. PubMed ID: 17562503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of clinico-radiologic-pathologic diagnosis of diffuse parenchymal lung diseases in children in China.
    Xu D; Chen Z; Chen H; Huang R; Zhao S; Liu X; Zhou C; Peng Y; Yuan X; Zou J; Zhang H; Zhao D; Liu E; Zheng Y; Zhong L; Lu M; Lu J; Nong G
    PLoS One; 2015; 10(1):e0116930. PubMed ID: 25569558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric interstitial lung disease revisited.
    Fan LL; Deterding RR; Langston C
    Pediatr Pulmonol; 2004 Nov; 38(5):369-78. PubMed ID: 15376335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical profile of interstitial lung disease in Indian children.
    Sankar J; Pillai MS; Sankar MJ; Lodha R; Kabra SK
    Indian Pediatr; 2013 Jan; 50(1):127-33. PubMed ID: 22728620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surfactant lipidomics in healthy children and childhood interstitial lung disease.
    Griese M; Kirmeier HG; Liebisch G; Rauch D; Stückler F; Schmitz G; Zarbock R;
    PLoS One; 2015; 10(2):e0117985. PubMed ID: 25692779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interstitial lung disease in systemic sclerosis].
    Mouthon L; Berezné A; Brauner M; Kambouchner M; Guillevin L; Valeyre D
    Rev Mal Respir; 2007 Oct; 24(8):1035-46. PubMed ID: 18033190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease.
    Kim Y; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
    Tohoku J Exp Med; 2018 Nov; 246(3):147-153. PubMed ID: 30405002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
    Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
    Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interstitial Lung Disease in Women of Child-Bearing Age.
    Mylvaganam R; Dua S; Nelson-Piercy C; Mathur A
    Semin Respir Crit Care Med; 2017 Apr; 38(2):185-190. PubMed ID: 28561249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etiologic spectrum of interstitial lung diseases in Chinese children older than 2 years of age.
    Tang X; Li H; Liu H; Xu H; Yang H; Liu J; Zhao S
    Orphanet J Rare Dis; 2020 Jan; 15(1):25. PubMed ID: 31969166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pathogenesis of interstitial lung diseases in children.
    Clement A; Henrion-Caude A; Fauroux B
    Paediatr Respir Rev; 2004 Jun; 5(2):94-7. PubMed ID: 15135117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
    Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H
    PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Derivation and Validation of a Diagnostic Prediction Tool for Interstitial Lung Disease.
    Pugashetti JV; Kitich A; Alqalyoobi S; Maynard-Paquette AC; Pritchard D; Graham J; Boctor N; Kulinich A; Lafond E; Foster E; Mendez C; Choudhry S; Chalaoui J; Morisset J; Kadoch M; Oldham JM
    Chest; 2020 Aug; 158(2):620-629. PubMed ID: 32184110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise Pathophysiology in Interstitial Lung Disease.
    Molgat-Seon Y; Schaeffer MR; Ryerson CJ; Guenette JA
    Clin Chest Med; 2019 Jun; 40(2):405-420. PubMed ID: 31078218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive Factors for the Long-Term Deterioration of Pulmonary Function in Interstitial Lung Disease Associated with Anti-Aminoacyl-tRNA Synthetase Antibodies.
    Yamakawa H; Hagiwara E; Kitamura H; Iwasawa T; Otoshi R; Aiko N; Katano T; Shintani R; Ikeda S; Okuda R; Sekine A; Baba T; Iso S; Kuwano K; Sato S; Ogura T
    Respiration; 2018; 96(3):210-221. PubMed ID: 29768275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory bronchiolitis-interstitial lung disease: long-term outcome.
    Portnoy J; Veraldi KL; Schwarz MI; Cool CD; Curran-Everett D; Cherniack RM; King TE; Brown KK
    Chest; 2007 Mar; 131(3):664-671. PubMed ID: 17356078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary function testing in interstitial lung diseases.
    Chetta A; Marangio E; Olivieri D
    Respiration; 2004; 71(3):209-13. PubMed ID: 15133338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of pulmonary function tests and biomarkers studies to diagnose and follow-up interstitial lung disease in systemic sclerosis].
    Hua-Huy T; Rivière S; Tiev KP; Dinh-Xuan AT
    Rev Pneumol Clin; 2014 Dec; 70(6):335-42. PubMed ID: 25457218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous Pulmonary Phenotypes in Filamin A Mutation-Related Lung Disease.
    Shah AS; Black ED; Simon DM; Gambello MJ; Garber KB; Iannucci GJ; Riedesel EL; Kasi AS
    Pediatr Allergy Immunol Pulmonol; 2021 Mar; 34(1):7-14. PubMed ID: 33734874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.